203 related articles for article (PubMed ID: 25203549)
1. [Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Nosseir NS; Michels G; Pfister R; Adam R; Wiesen MH; Müller C
Dtsch Med Wochenschr; 2014 Sep; 139(38):1889-94. PubMed ID: 25203549
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Mensa J; Soriano A; Llinares P; Barberán J; Montejo M; Salavert M; Alvarez-Rocha L; Maseda E; Moreno A; Pasquau J; Gómez J; Parra J; Candel F; Azanza JR; García JE; Marco F; Soy D; Grau S; Arias J; Fortún J; de Alarcón CA; Picazo J; ; ;
Rev Esp Quimioter; 2013 Jan; 26 Suppl 1():1-84. PubMed ID: 23824510
[No Abstract] [Full Text] [Related]
3. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock.
Vázquez M; Fagiolino P; Boronat A; Buroni M; Maldonado C
Int J Clin Pharmacol Ther; 2008 Mar; 46(3):140-5. PubMed ID: 18397685
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
5. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
Wolff F; Deprez G; Seyler L; Taccone F; Hites M; Gulbis B; Vincent JL; Jacobs F; Cotton F
Talanta; 2013 Jan; 103():153-60. PubMed ID: 23200371
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial management of sepsis and septic shock.
Sharma S; Kumar A
Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].
Bellmann R
Med Klin Intensivmed Notfmed; 2014 Apr; 109(3):162-6. PubMed ID: 24643839
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological rationale for choice of antibiotics for intraabdominal infections].
Mazzei T; Novelli A
Infez Med; 2008 Feb; 16 Suppl 1():31-45. PubMed ID: 18382149
[TBL] [Abstract][Full Text] [Related]
9. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
Reed MD
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
[TBL] [Abstract][Full Text] [Related]
10. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and pharmacodynamics of antibiotics in intensive care].
Sörgel F; Höhl R; Glaser R; Stelzer C; Munz M; Vormittag M; Kinzig M; Bulitta J; Landersdorfer C; Junger A; Christ M; Wilhelm M; Holzgrabe U
Med Klin Intensivmed Notfmed; 2017 Feb; 112(1):11-23. PubMed ID: 27778050
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial agents in treatment of MRSA infections.
Johnson MD; Decker CF
Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
[No Abstract] [Full Text] [Related]
13. Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring.
Tröger U; Drust A; Martens-Lobenhoffer J; Tanev I; Braun-Dullaeus RC; Bode-Böger SM
Int J Antimicrob Agents; 2012 Oct; 40(4):370-2. PubMed ID: 22795654
[TBL] [Abstract][Full Text] [Related]
14. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
[TBL] [Abstract][Full Text] [Related]
15. Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Kruger WA; Mayer K; Pletz MW; Storzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
Anaesthesist; 2019 Feb; 68(Suppl 1):40-62. PubMed ID: 29383395
[TBL] [Abstract][Full Text] [Related]
16. Optimizing antimicrobial therapy in sepsis and septic shock.
Kumar A
Crit Care Clin; 2009 Oct; 25(4):733-51, viii. PubMed ID: 19892250
[TBL] [Abstract][Full Text] [Related]
17. Effect of severity of sepsis on tissue concentrations of linezolid.
Thallinger C; Buerger C; Plock N; Kljucar S; Wuenscher S; Sauermann R; Kloft C; Joukhadar C
J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
Muller AE; Huttner B; Huttner A
Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid for pediatric infections].
Moulin F; Hériveaux B; Vallet C
Arch Pediatr; 2010 Jun; 17(6):762-3. PubMed ID: 20654880
[No Abstract] [Full Text] [Related]
20. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
